Literature DB >> 28384687

Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.

Steven J Katz1, Nancy K Janz2, Paul Abrahamse3, Lauren P Wallner3, Sarah T Hawley4, Lawrence C An3, Kevin C Ward5, Ann S Hamilton6, Monica Morrow7, Reshma Jagsi8.   

Abstract

Importance: Guidelines assert that contralateral prophylactic mastectomy (CPM) should be discouraged in patients without an elevated risk for a second primary breast cancer. However, little is known about the impact of surgeons discouraging CPM on patient care satisfaction or decisions to seek treatment from another clinician. Objective: To examine the association between patient report of first-surgeon recommendation against CPM and the extent of discussion about it with 3 outcomes: patient satisfaction with surgery decisions, receipt of a second opinion, and receipt of surgery by a second surgeon. Design, Setting, and Participants: This population-based survey study was conducted in Georgia and California. We identified 3880 women with stages 0 to II breast cancer treated in 2013-2014 through the Surveillance, Epidemiology, and End Results registries of Georgia and Los Angeles County. Surveys were sent approximately 2 months after surgery (71% response rate, n = 2578). In this analysis conducted from February to May 2016, we included patients with unilateral breast cancer who considered CPM (n = 1140). Patients were selected between July 2013 and September 2014. Main Outcomes and Measures: We examined report of surgeon recommendations, level of discussion about CPM, satisfaction with surgical decision making, receipt of second surgical opinion, and surgery from a second surgeon.
Results: The mean (SD) age of patients included in this study was 56 (10.6) years. About one-quarter of patients (26.7%; n = 304) reported that their first surgeon recommended against CPM and 30.1% (n = 343) reported no substantial discussion about CPM. Dissatisfaction with surgery decision was uncommon (7.6%; n = 130), controlling for clinical and demographic characteristics. One-fifth of patients (20.6%; n = 304) had a second opinion about surgical options and 9.8% (n = 158) had surgery performed by a second surgeon. Dissatisfaction was very low (3.9%; n = 42) among patients who reported that their surgeon did not recommend against CPM but discussed it. Dissatisfaction was substantively higher for those whose surgeon recommended against CPM with no substantive discussion (14.5%; n = 37). Women who received a recommendation against CPM were not more likely to seek a second opinion (17.1% among patients with recommendation against CPM vs 15.1% of others; P = .52) nor to receive surgery by a second surgeon (7.9% among patients with recommendation against CPM vs 8.3% of others; P = .88). Conclusions and Relevance: Most patients are satisfied with surgical decision making. First-surgeon recommendation against CPM does not appear to substantively increase patient dissatisfaction, use of second opinions, or loss of the patient to a second surgeon.

Entities:  

Mesh:

Year:  2017        PMID: 28384687      PMCID: PMC5520628          DOI: 10.1001/jamasurg.2017.0458

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   16.681


  17 in total

1.  Does physician communication style impact patient report of decision quality for breast cancer treatment?

Authors:  Kathryn A Martinez; Ken Resnicow; Geoffrey C Williams; Marlene Silva; Paul Abrahamse; Dean A Shumway; Lauren P Wallner; Steven J Katz; Sarah T Hawley
Journal:  Patient Educ Couns       Date:  2016-06-22

2.  Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.

Authors:  Emily Bellavance; Jeffrey Peppercorn; Shari Kronsberg; Rachel Greenup; Jason Keune; Julie Lynch; Deborah Collyar; Laurence Magder; Jon Tilburt; Fay Hlubocky; Katharine Yao
Journal:  Ann Surg Oncol       Date:  2016-05-11       Impact factor: 5.344

3.  Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.

Authors:  Laura Grimmer; Erik Liederbach; Jose Velasco; Catherine Pesce; Chi-Hsiung Wang; Katharine Yao
Journal:  J Am Coll Surg       Date:  2015-04-23       Impact factor: 6.113

4.  Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.

Authors:  Sarah T Hawley; Reshma Jagsi; Monica Morrow; Nancy K Janz; Ann Hamilton; John J Graff; Steven J Katz
Journal:  JAMA Surg       Date:  2014-06       Impact factor: 14.766

5.  Surgeon-level variation in patients' appraisals of their breast cancer treatment experiences.

Authors:  Sarah T Hawley; Sarah E Lillie; Arden Morris; John J Graff; Ann Hamilton; Steven J Katz
Journal:  Ann Surg Oncol       Date:  2012-10-06       Impact factor: 5.344

6.  Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.

Authors:  Stephanie M Wong; Rachel A Freedman; Yasuaki Sagara; Fatih Aydogan; William T Barry; Mehra Golshan
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

7.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.

Authors:  Hazel B Nichols; Amy Berrington de González; James V Lacey; Philip S Rosenberg; William F Anderson
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

8.  Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy.

Authors:  Toni Musiello; Emelie Bornhammar; Christobel Saunders
Journal:  ANZ J Surg       Date:  2012-10-08       Impact factor: 1.872

9.  Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.

Authors:  Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John J Graff; Nancy K Janz; Monica Morrow; Reshma Jagsi; Barbara Salem; Steven J Katz
Journal:  J Natl Cancer Inst       Date:  2009-08-31       Impact factor: 13.506

10.  Psychometric properties of a brief measure of autonomy support in breast cancer patients.

Authors:  Dean Shumway; Kent A Griffith; Reshma Jagsi; Sheryl G Gabram; Geoffrey C Williams; Ken Resnicow
Journal:  BMC Med Inform Decis Mak       Date:  2015-07-09       Impact factor: 2.796

View more
  9 in total

1.  Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.

Authors:  Thomas A D'Agostino; Abenaa M Brewster; Susan K Peterson; Isabelle Bedrosian; Patricia A Parker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

Review 2.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

3.  Patient decision aid for contralateral prophylactic mastectomy for use in the consultation: a feasibility study.

Authors:  J E Squires; D Stacey; M Coughlin; M Greenough; A Roberts; K Dorrance; M Clemons; J M Caudrelier; I D Graham; J Zhang; M Demery Varin; A Arnaout
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

4.  Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study.

Authors:  L Findlay-Shirras; I Lima; G Smith; M Clemons; A Arnaout
Journal:  Breast Cancer Res Treat       Date:  2020-10-30       Impact factor: 4.872

5.  Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.

Authors:  J E Squires; S N Simard; S Asad; D Stacey; I D Graham; M Coughlin; M Clemons; J M Grimshaw; J Zhang; J M Caudrelier; A Arnaout
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

6.  "I don't want to take chances.": A qualitative exploration of surgical decision making in young breast cancer survivors.

Authors:  Shoshana M Rosenberg; Mary L Greaney; Andrea F Patenaude; Karen R Sepucha; Meghan E Meyer; Ann H Partridge
Journal:  Psychooncology       Date:  2018-04-06       Impact factor: 3.894

7.  Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer.

Authors:  Lauren P Wallner; David Reyes-Gastelum; Ann S Hamilton; Kevin C Ward; Sarah T Hawley; Megan R Haymart
Journal:  J Clin Oncol       Date:  2019-07-08       Impact factor: 50.717

8.  Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.

Authors:  Lauren P Wallner; Mousumi Banerjee; David Reyes-Gastelum; Ann S Hamilton; Kevin C Ward; Carrie Lubitz; Sarah T Hawley; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

9.  Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.

Authors:  Steven J Katz; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Monica Morrow; Reshma Jagsi; Timothy P Hofer
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 16.681

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.